Login| Sign Up| Help| Contact|

Patent Searching and Data


Title:
HETEROCYCLE FUSED PYRIMIDINE COMPOUND AND USE THEREOF
Document Type and Number:
WIPO Patent Application WO/2024/022519
Kind Code:
A1
Abstract:
Provided are a compound of formula (I) or a pharmaceutically acceptable salt thereof as a USP1 inhibitor and a pharmaceutical composition comprising the compound or the pharmaceutically acceptable salt thereof. The compound and the pharmaceutical composition can be used for preventing or treating diseases related to USP1.

More Like This:
JP20061826487-MEMBERED HETEROCYCLIC DERIVATIVE
JPH06340662MONOBACTAM HYDRAZIDE COMPOUND CONTAINING CATECHOL SULFONIC ACID GROUP
JP5713511Oxadiazole inhibitor for leukotriene production
Inventors:
ZHU WEI (CN)
CHEN XIANG (CN)
WANG TAO (CN)
SUN TIANWEN (CN)
LI ZHENGTAO (CN)
Application Number:
PCT/CN2023/109974
Publication Date:
February 01, 2024
Filing Date:
July 28, 2023
Export Citation:
Click for automatic bibliography generation   Help
Assignee:
SIMCERE ZAIMING PHARMACEUTICAL CO LTD (CN)
International Classes:
C07D417/14; A61K31/519; A61P35/00; C07D487/04
Domestic Patent References:
WO2021175270A12021-09-10
WO2020139988A12020-07-02
WO2020068729A12020-04-02
WO2018049152A12018-03-15
Foreign References:
CN108473495A2018-08-31
CN113164485A2021-07-23
CN113474346A2021-10-01
CN1503797A2004-06-09
Download PDF:
View/Download PDF      PDF Help



 
Previous Patent: FOUR-WAY VALVE

Next Patent: TOXIN MOLECULE SUITABLE FOR ANTIBODY-DRUG CONJUGATE